- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 453
DiscGenics discloses $50m series C
Ci:z Investment led a round also backed by CareNet that advanced the total raised by the spinal disease drug developer to more than $70m.
Aug 28, 2020Socure curates $35m in funding
Customer identity analytics provider Socure collected Citi Ventures and Wells Fargo Strategic Capital in a round that boosted its total funding to $96m.
Aug 28, 2020Split opens up for $33m series C
M12, ServiceNow, Atlassian and Comcast Ventures all contributed to bring feature flagging deployment platform Split's overall funding to $60m.
Aug 28, 2020Acto accomplishes series A close
Salesforce Ventures contributed to an $11.5m round that will fund the addition of more features to Acto's mobile drug information platform.
Aug 28, 2020BMS to fork over cash for Forbius
Cancer and fibrosis therapy developer Forbius has agreed to be acquired by Bristol Myers Squibb nine years after it was spun off by YM BioSciences.
Aug 27, 2020Daily deal net: August 27, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 27, 2020Kymeta climbs to $85m
Bill Gates has returned to lead an $85m round for satellite internet provider Kymeta, which has now raised more than $280m since it was set up to advance Duke University research.
Aug 27, 2020Desktop Metal irons out $2.5bn reverse merger
Desktop Metal, backed by a large consortium of corporates, will merge with special purpose acquisition company Trine to list on the NYSE at a $2.5bn valuation.
Aug 27, 2020BMS sweeps up Forbius
Toronto Innovation Acceleration Partners has scored an exit having invested at least twice in cancer and fibrosis therapy developer Forbius.
Aug 27, 2020Freenome finishes $270m series C
Novartis and existing investors GV, Kaiser Permanente Ventures and Roche Venture Fund helped the cancer test developer push its total funding past the $500m mark.
Aug 27, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


